New York, NY, United States of America

Slawomir Kosinski

This inventor holds 1 USPTO granted patent. Top assignee: Sloan-Kettering Institute for Cancer Research. Active years: 1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Slawomir Kosinski. Retrieved from https://idiyas.com/inventor/slawomir-kosinski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Slawomir Kosinski: Innovator in Cell Cloning Technology

Introduction

Slawomir Kosinski is a notable inventor based in New York, NY, who has made significant contributions to the field of cell biology. His innovative work focuses on methods for cloning lymphoblastoid cells, which are crucial for various medical and research applications.

Latest Patents

Kosinski holds a patent for a "Method for cloning lymphoblastoid cells." This patent describes a method of growing cells, particularly those transformed by the Epstein Barr Virus, in agarose. The method involves at least one agarose layer containing human fibroblast cells and another layer with irradiated fibroblasts, along with the specific growing cells suspended within.

Career Highlights

Slawomir Kosinski is affiliated with the Sloan Kettering Institute for Cancer Research, where he conducts research that contributes to advancements in cancer treatment and cell biology. His work is instrumental in understanding how to manipulate and grow specific cell types for therapeutic purposes.

Collaborations

Kosinski collaborates with various professionals in his field, including his coworker Ulrich Hammerling, to further enhance the research and development of cell cloning techniques.

Conclusion

Slawomir Kosinski's innovative methods in cell cloning represent a significant advancement in medical research, particularly in the context of cancer treatment. His contributions continue to influence the scientific community and pave the way for future discoveries.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…